Theranostics Health

About:

Theranostics Health is a proteomics-based diagnostics company that provides research services for drug development companies.

Website: http://theranosticshealth.com

Twitter/X: theranosticsinc

Top Investors: Maryland Venture Fund

Description:

Theranostics Health is a proteomics-based diagnostics company that provides research services to drug development companies and is developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor. Its technologies utilize Laser Capture Microdissection (LCM) and Reverse-phase Protein MicroArrays (RPMA) assays to accurately measure drug targets and their signaling pathways within tumor cells. Its technologies are of particular use for companies developing Molecular Targeted Therapies and allow insights into the phospho-activation status of drug targets, their downstream pathways and potential survival mechanisms or pathways within targeted cell populations and are utilized in a translational research manner from preclinical SAR-type studies through to Phase II clinical trials.

Total Funding Amount:

$5.48M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)TheranosticsHealth.com

Founders:

Emanuel Petricoin, Lance Liotta

Number of Employees:

11-50

Last Funding Date:

2015-06-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai